resumed: Oppenheimer Recommends Portage Biotech Inc (NASDAQ:PRTG) Stock to “an Outperform”
Oppenheimer raised the price target for the Portage Biotech Inc (NASDAQ:PRTG) stock to “an Outperform”. The rating was released on July 18, 2022, according to finviz. The research report from Oppenheimer has initiated the stock to Outperform, with a price target set at $30. The stock was initiated by B. Riley Securities, who disclosed in […]